Stay updated with breaking news from Diffusion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) is scheduled to post its quarterly earnings results on Friday, March 24th. Diffusion Pharmaceuticals Stock Performance Shares of DFFN stock traded down $0.19 on Thursday, hitting $5.65. The company had a trading volume of 4,032 shares, compared to its average volume of 7,947. The firm has a market cap […]
Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) will announce its earnings results on Friday, March 24th. Diffusion Pharmaceuticals Stock Down 3.3 % Diffusion Pharmaceuticals stock traded down $0.19 during mid-day trading on Thursday, reaching $5.65. 4,032 shares of the company’s stock were exchanged, compared to its average volume of 7,947. The business’s fifty day simple moving […]
Should You Buy or Sell Diffusion Pharmaceuticals Stock? Get The Latest DFFN Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Analysts at StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a report released on Thursday. The firm set a “hold” rating on the stock. Diffusion Pharmaceuticals Stock Up 0.3 % Shares of Diffusion Pharmaceuticals stock opened at $5.36 on Thursday. Diffusion Pharmaceuticals has a twelve month low of $4.64 and […]
(RTTNews) - Biopharmaceutical company Diffusion Pharmaceuticals Inc. (DFFN) said Monday in a letter to its stockholders that the Company's board o...